Stocks
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
Hims & Hers Health announced a new agreement with Eli Lilly allowing patients to purchase the drugmaker’s GLP-1 medications directly through its platform. Previously,...
Stocks
Watch live: Jim Cramer says an Anthropic IPO would be a cue to start buying again
Following the midterm elections that gave Democrats control of both chambers of Congress, financial markets have swung sharply, fueling concerns about the data center...
Stocks
Anthropic IPO announcement odds drop on Kalshi following midterms and AI sell-off
On Kalshi, the odds of Anthropic announcing an IPO before December fell to 57% from nearly 90% a week earlier. The probability of an...
Stocks
Nvidia, AMD and other chip stocks rebound. Is the ‘violent’ AI selloff over?
Nvidia, AMD and several other chip stocks rebounded on Friday after the sector’s worst selloff in six years. Shortly after the opening, Micron Technology...
Stocks
These three stars need to align before investors rush back into stocks, Bank of America strategist says
Michael Hartnett, Bank of America's chief investment strategist, does not plan to return immediately to the stock market after this week's steep decline. The...
Stocks
Our top 10 things to watch in the stock market Friday
Nasdaq futures are rebounding after the tech-heavy index posted its worst day in 19 months amid post-election concerns about a slowdown in data-center construction....
Stocks
Wall Street’s fear gauge may be flashing a buy sign
The Cboe Volatility Index's VIX jumped from 16.6 to 28.2 on Thursday, its biggest one-day move since April 2025's "Liberation" week for tariffs. According...
Stocks
Market sell-off hits hard: Advisors say ‘stay the course with an eye on buying’
More than three-quarters of the advisors surveyed by CNBC said they do not recommend changing portfolios after Thursday’s sharp decline, despite heavy selling of...